Abstract:RNAs with 5′‐triphosphate (ppp) are detected in the cytoplasm principally by the innate immune receptor RIG‐I, whose activation triggers a Type I interferon response. Cellular RNAs undergo post‐transcriptional modifications which ensures that self RNAs do not carry 5′ppp and/or blunt‐ends. We carried out a thorough biochemical characterization of RIG‐I complexes with RNAs carrying various end‐modifications as well as measured the effect of these end‐modifications on their signaling activity. We find that discrimination of RNA ligands occurs at multiple stages and signaling RNAs have high affinity and ATPase turnover rate and thus a high k atpase / K d . Our studies reveal that the autoinhibitory interface between CARD2 (second CARD) and Hel2i (Helicase 2 insertion domain) plays a critical role in RNA selectivity, wherein this interface acts as a “gate” that prevents cellular RNAs from generating productive complexes that can signal. It is thought that self RNAs like mRNAs are not recognized by RIG‐I because 5′ppp is capped by the addition of a 7‐methyl guanosine (m7G) (Cap‐0) and the 5′‐end nucleotide ribose is 2′‐O‐methylated (Cap‐1). We provide a structural and mechanistic basis for the exact roles of capping and 2′‐O‐methylation in evading RIG‐I recognition using enzymatic assays, X‐ray crystallography and cell‐based signaling studies. Surprisingly, we find that Cap‐0 and 5′ppp dsRNA have similar binding affinities, activate RIG‐I's ATPase to the same extent, and shows the same cellular signaling response. Three new crystal structures of RIG‐I complexes with dsRNA bearing 5′OH, 5′ppp, and 5′Cap‐0 reveal that RIG‐I accommodates m7G in a cavity created through conformational changes in helicase‐motif IVa without perturbing the triphosphate interactions. In contrast, Cap‐1 modifications abrogate RIG‐I signaling through a mechanism involving the H830 residue, wherein 2′‐O‐methylation works synergistically with m7G capping to weaken RNA affinity and ATPase activity. Our work provides new structural insights into the host and viral immune evasive mechanisms from RIG‐I explaining the complexity of cap structures over evolution. Support or Funding Information This work was supported by NIH grant GM111959 to Joseph Marcotrigiano and Smita S Patel.

An alternative mechanism for activation of innate immune signaling by MDA5

Molecular basis of autoimmune disease protection by MDA5 variants

Breaching Self-Tolerance to Alu Duplex RNA Underlies MDA5-Mediated Inflammation

Pattern Recognition and Signaling Mechanisms of RIG-I and MDA5

Kinetic discrimination of self/non-self RNA by the ATPase activity of RIG-I and MDA5

Structural Basis of Double-Stranded RNA Recognition by the RIG-I Like Receptor MDA5.

Ordered assembly of the cytosolic RNA-sensing MDA5-MAVS signaling complex via binding to unanchored K63-linked poly-ubiquitin chains

MDA5 ISGylation is crucial for immune signaling to control viral replication and pathogenesis

Observation of Higher-Order Assemblies Controlled by Protein One-dimensional Movement

MDA5 detects the double-stranded RNA replicative form in picornavirus-infected cells.

Negative Regulation of MDA5- but Not RIG-I-mediated Innate Antiviral Signaling by the Dihydroxyacetone Kinase.

Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses

Trim65-Catalized Ubiquitination is Essential for Mda5-Mediated Antiviral Innate Immunity

Research Note: Interactions among the MDA5, MAVS, and STING signaling pathways in chicken cells

Comparative Structure and Function Analysis of the RIG-I-Like Receptors: RIG-I and MDA5

Deficiency for SAMHD1 activates MDA5 in a cGAS/STING-dependent manner

Structural and biochemical studies of RIG-I antiviral signaling

Structural and Mechanistic Basis for Self Versus Non‐self RNA Discrimination by the Innate Immune Receptor RIG‐I

MDA5 is SUMOylated by PIAS2β in the upregulation of type I interferon signaling

Helicase protein DDX11 as a novel antiviral factor promoting RIG-I-MAVS-mediated signaling pathway

CD11b/CD18 (Mac-1) is a Novel Surface Receptor for Extracellular Double-Stranded RNA to Mediate Cellular Inflammatory Responses